Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Kaempferol Absorption and Pharmacokinetics Evaluation

University of Pittsburgh · with Otsuka Pharmaceutical Co., Ltd. · NCT07322406

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–70 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
120
US sites recruiting
1
Study start
December 9, 2025
Record last updated
March 23, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This study is a multi-site clinical trial designed to evaluate how the body absorbs and processes Kaempferol, a naturally occurring compound found in many plant-based foods. The primary purpose of the study is to measure the pharmacokinetics and biological absorption of Kaempferol in healthy adults.

Participants will receive Kaempferol and undergo scheduled blood and urine collections over a short study period. These samples will be used to measure Kaempferol levels in the body and to assess safety and tolerability. In addition, selected biological samples will be analyzed to explore molecular changes associated with Kaempferol exposure using advanced laboratory methods.

The study will be conducted at multiple research centers in the United States using a standardized protocol to ensure consistency across sites. The information collected will help improve understanding of how Kaempferol is absorbed and metabolized in humans and will support future research and regulatory evaluation.

Being studied: Kaempferol

Conditions: No Disease; Mitochondria Health; Longevity; Pharmacokinetics and Biological Absorption of Kaempferol in Healthy Adult; Healthy Volunteers

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

Adults aged 18 to 70 years

  • Healthy volunteers as determined by medical history and screening assessment
  • Ability to understand the study procedures and provide informed consent
  • Willingness and ability to comply with all study procedures, including dietary restrictions, clinic visits, blood draws, urine collection, and follow-up assessments
  • Willingness to abstain from restricted foods, beverages, and supplements as specified in the study protocol during the study period

Exclusion Criteria

  • Known allergy or hypersensitivity to Kaempferol or related flavonoids
  • Pregnancy or breastfeeding
  • Presence of significant acute or chronic medical conditions that could increase risk or interfere with study outcomes, including but not limited to:
  • Active or chronic infections
  • Cancer
  • Cardiovascular disease
  • Neurological or neurodegenerative disorders
  • Metabolic or systemic inflammatory conditions
  • Use of prescription medications or supplements known to interfere with Kaempferol metabolism or pharmacokinetic assessment
  • Blood donation within 8 weeks prior to study enrollment
  • Participation in another interventional clinical study within a timeframe that could interfere with study results or participant safety
  • Any condition or circumstance that, in the judgment of the study investigator, would make participation unsafe or compromise data integrity

Recruiting US locations

  • University of Pittsburgh

    Pittsburgh, PA 15219

    Site contact: Stephanie K Montgomery, MBA MPH · 6102094365 · SKM66@pitt.edu

Study contacts (from the official record)

  • Afshin Beheshti, PhD · 6173082540 · beheshti@pitt.edu
  • Arabella Johnson · +13155659660 · AAJ28@pitt.edu
All nutrition & metabolism studies in Pennsylvania →
Kaempferol Absorption and Pharmacokinetics Evaluation (NCT07322406) | Bored Studies